Introducing 1,3-beta-d-glucan for screening and diagnosis of invasive fungal diseases in Australian high-risk haematology patients: is there a clinical benefit?
Saved in:
| Title: | Introducing 1,3-beta-d-glucan for screening and diagnosis of invasive fungal diseases in Australian high-risk haematology patients: is there a clinical benefit? |
|---|---|
| Authors: | Garnham K; Centre for Infectious Diseases and Microbiology Laboratory Services, New South Wales Health Pathology, Institute of Clinical Pathology and Medical Research, Westmead Hospital, Sydney, New South Wales, Australia.; Marie Bashir Institute for Infectious Diseases and Biosecurity, The University of Sydney, Sydney, New South Wales, Australia., Halliday CL; Centre for Infectious Diseases and Microbiology Laboratory Services, New South Wales Health Pathology, Institute of Clinical Pathology and Medical Research, Westmead Hospital, Sydney, New South Wales, Australia.; Marie Bashir Institute for Infectious Diseases and Biosecurity, The University of Sydney, Sydney, New South Wales, Australia., Rai NJ; Clinical Trials Unit, Centre for Infectious Diseases and Microbiology, Westmead Hospital, Sydney, New South Wales, Australia., Jayawardena M; Centre for Infectious Diseases and Microbiology Laboratory Services, New South Wales Health Pathology, Institute of Clinical Pathology and Medical Research, Westmead Hospital, Sydney, New South Wales, Australia., Hasan T; Clinical Trials Unit, Centre for Infectious Diseases and Microbiology, Westmead Hospital, Sydney, New South Wales, Australia.; Department of Infectious Diseases, Westmead Hospital, Sydney, New South Wales, Australia., Kok J; Centre for Infectious Diseases and Microbiology Laboratory Services, New South Wales Health Pathology, Institute of Clinical Pathology and Medical Research, Westmead Hospital, Sydney, New South Wales, Australia.; Marie Bashir Institute for Infectious Diseases and Biosecurity, The University of Sydney, Sydney, New South Wales, Australia.; Clinical Trials Unit, Centre for Infectious Diseases and Microbiology, Westmead Hospital, Sydney, New South Wales, Australia.; Department of Infectious Diseases, Westmead Hospital, Sydney, New South Wales, Australia., Nayyar V; Department of Intensive Care Medicine, Westmead Hospital, Sydney, New South Wales, Australia., Gottlieb DJ; Department of Haematology Medicine, Westmead Hospital, Sydney, New South Wales, Australia., Gilroy NM; Marie Bashir Institute for Infectious Diseases and Biosecurity, The University of Sydney, Sydney, New South Wales, Australia.; Clinical Trials Unit, Centre for Infectious Diseases and Microbiology, Westmead Hospital, Sydney, New South Wales, Australia.; Department of Infectious Diseases, Westmead Hospital, Sydney, New South Wales, Australia., Chen SC; Centre for Infectious Diseases and Microbiology Laboratory Services, New South Wales Health Pathology, Institute of Clinical Pathology and Medical Research, Westmead Hospital, Sydney, New South Wales, Australia.; Marie Bashir Institute for Infectious Diseases and Biosecurity, The University of Sydney, Sydney, New South Wales, Australia.; Clinical Trials Unit, Centre for Infectious Diseases and Microbiology, Westmead Hospital, Sydney, New South Wales, Australia.; Department of Infectious Diseases, Westmead Hospital, Sydney, New South Wales, Australia. |
| Source: | Internal medicine journal [Intern Med J] 2022 Mar; Vol. 52 (3), pp. 426-435. |
| Publication Type: | Journal Article |
| Journal Info: | Publisher: Blackwell Science Asia Country of Publication: Australia NLM ID: 101092952 Publication Model: Print Cited Medium: Internet ISSN: 1445-5994 (Electronic) Linking ISSN: 14440903 NLM ISO Abbreviation: Intern Med J Subsets: MEDLINE |
| Database: | MEDLINE Ultimate |
|
Full text is not displayed to guests.
Login for full access.
|
|
| FullText | Links: – Type: pdflink Text: Availability: 1 |
|---|---|
| Header | DbId: mdl DbLabel: MEDLINE Ultimate An: 32896984 AccessLevel: 2 PubType: Academic Journal PubTypeId: academicJournal PreciseRelevancyScore: 0 |
| IllustrationInfo | |
| Items | – Name: Title Label: Title Group: Ti Data: Introducing 1,3-beta-d-glucan for screening and diagnosis of invasive fungal diseases in Australian high-risk haematology patients: is there a clinical benefit? – Name: Author Label: Authors Group: Au Data: <searchLink fieldCode="AU" term="%22Garnham+K%22">Garnham K</searchLink>; Centre for Infectious Diseases and Microbiology Laboratory Services, New South Wales Health Pathology, Institute of Clinical Pathology and Medical Research, Westmead Hospital, Sydney, New South Wales, Australia.; Marie Bashir Institute for Infectious Diseases and Biosecurity, The University of Sydney, Sydney, New South Wales, Australia.<br /><searchLink fieldCode="AU" term="%22Halliday+CL%22">Halliday CL</searchLink>; Centre for Infectious Diseases and Microbiology Laboratory Services, New South Wales Health Pathology, Institute of Clinical Pathology and Medical Research, Westmead Hospital, Sydney, New South Wales, Australia.; Marie Bashir Institute for Infectious Diseases and Biosecurity, The University of Sydney, Sydney, New South Wales, Australia.<br /><searchLink fieldCode="AU" term="%22Rai+NJ%22">Rai NJ</searchLink>; Clinical Trials Unit, Centre for Infectious Diseases and Microbiology, Westmead Hospital, Sydney, New South Wales, Australia.<br /><searchLink fieldCode="AU" term="%22Jayawardena+M%22">Jayawardena M</searchLink>; Centre for Infectious Diseases and Microbiology Laboratory Services, New South Wales Health Pathology, Institute of Clinical Pathology and Medical Research, Westmead Hospital, Sydney, New South Wales, Australia.<br /><searchLink fieldCode="AU" term="%22Hasan+T%22">Hasan T</searchLink>; Clinical Trials Unit, Centre for Infectious Diseases and Microbiology, Westmead Hospital, Sydney, New South Wales, Australia.; Department of Infectious Diseases, Westmead Hospital, Sydney, New South Wales, Australia.<br /><searchLink fieldCode="AU" term="%22Kok+J%22">Kok J</searchLink>; Centre for Infectious Diseases and Microbiology Laboratory Services, New South Wales Health Pathology, Institute of Clinical Pathology and Medical Research, Westmead Hospital, Sydney, New South Wales, Australia.; Marie Bashir Institute for Infectious Diseases and Biosecurity, The University of Sydney, Sydney, New South Wales, Australia.; Clinical Trials Unit, Centre for Infectious Diseases and Microbiology, Westmead Hospital, Sydney, New South Wales, Australia.; Department of Infectious Diseases, Westmead Hospital, Sydney, New South Wales, Australia.<br /><searchLink fieldCode="AU" term="%22Nayyar+V%22">Nayyar V</searchLink>; Department of Intensive Care Medicine, Westmead Hospital, Sydney, New South Wales, Australia.<br /><searchLink fieldCode="AU" term="%22Gottlieb+DJ%22">Gottlieb DJ</searchLink>; Department of Haematology Medicine, Westmead Hospital, Sydney, New South Wales, Australia.<br /><searchLink fieldCode="AU" term="%22Gilroy+NM%22">Gilroy NM</searchLink>; Marie Bashir Institute for Infectious Diseases and Biosecurity, The University of Sydney, Sydney, New South Wales, Australia.; Clinical Trials Unit, Centre for Infectious Diseases and Microbiology, Westmead Hospital, Sydney, New South Wales, Australia.; Department of Infectious Diseases, Westmead Hospital, Sydney, New South Wales, Australia.<br /><searchLink fieldCode="AU" term="%22Chen+SC%22">Chen SC</searchLink>; Centre for Infectious Diseases and Microbiology Laboratory Services, New South Wales Health Pathology, Institute of Clinical Pathology and Medical Research, Westmead Hospital, Sydney, New South Wales, Australia.; Marie Bashir Institute for Infectious Diseases and Biosecurity, The University of Sydney, Sydney, New South Wales, Australia.; Clinical Trials Unit, Centre for Infectious Diseases and Microbiology, Westmead Hospital, Sydney, New South Wales, Australia.; Department of Infectious Diseases, Westmead Hospital, Sydney, New South Wales, Australia. – Name: TitleSource Label: Source Group: Src Data: <searchLink fieldCode="JN" term="%22101092952%22">Internal medicine journal</searchLink> [Intern Med J] 2022 Mar; Vol. 52 (3), pp. 426-435. – Name: TypePub Label: Publication Type Group: TypPub Data: Journal Article – Name: TitleSource Label: Journal Info Group: Src Data: <i>Publisher: </i><searchLink fieldCode="PB" term="%22Blackwell+Science+Asia%22">Blackwell Science Asia </searchLink><i>Country of Publication: </i>Australia <i>NLM ID: </i>101092952 <i>Publication Model: </i>Print <i>Cited Medium: </i>Internet <i>ISSN: </i>1445-5994 (Electronic) <i>Linking ISSN: </i><searchLink fieldCode="IS" term="%2214440903%22">14440903 </searchLink><i>NLM ISO Abbreviation: </i>Intern Med J <i>Subsets: </i>MEDLINE |
| PLink | https://search.ebscohost.com/login.aspx?direct=true&site=eds-live&db=mdl&AN=32896984 |
| RecordInfo | BibRecord: BibEntity: Identifiers: – Type: doi Value: 10.1111/imj.15046 Languages: – Code: eng Text: English PhysicalDescription: Pagination: StartPage: 426 Titles: – TitleFull: Introducing 1,3-beta-d-glucan for screening and diagnosis of invasive fungal diseases in Australian high-risk haematology patients: is there a clinical benefit? Type: main BibRelationships: HasContributorRelationships: – PersonEntity: Name: NameFull: Garnham K – PersonEntity: Name: NameFull: Halliday CL – PersonEntity: Name: NameFull: Rai NJ – PersonEntity: Name: NameFull: Jayawardena M – PersonEntity: Name: NameFull: Hasan T – PersonEntity: Name: NameFull: Kok J – PersonEntity: Name: NameFull: Nayyar V – PersonEntity: Name: NameFull: Gottlieb DJ – PersonEntity: Name: NameFull: Gilroy NM – PersonEntity: Name: NameFull: Chen SC IsPartOfRelationships: – BibEntity: Dates: – D: 01 M: 03 Text: 2022 Mar Type: published Y: 2022 Identifiers: – Type: issn-electronic Value: 1445-5994 Numbering: – Type: volume Value: 52 – Type: issue Value: 3 Titles: – TitleFull: Internal medicine journal Type: main |
| ResultId | 1 |